DOI: 10.5281/zenodo.

10559810

SHAPING THE FUTURE: A LITERATURE REVIEW ON MACHINE

LEARNING APPLICATIONS FOR PREDICTING CANCER
RECURRENCE

SENTHILKUMAR. S
Department of Computer Science and Engineering, University College of Engineering BIT Campus,
Tiruchirappalli. Email: senthilucepkt@gmail.com
SATHEESH KUMAR. N
Department of Information Technology, University College of Engineering Villupuram.
Email: nsathish8984@gmail.com

Abstract
A thorough summary of the possibilities for improving cancer recurrence prediction with machine learning (ML)
is given in this current review of the research. Numerous research analyzed demonstrate the effectiveness of
various machine learning algorithms and methodologies in precisely detecting patterns and forecasting the
likelihood of a cancer recurrence. Even with these developments, this field still has opportunities for research and
development. Future studies should focus on utilizing deep learning models and ensemble techniques—two recent
developments in machine learning—to increase the prediction capacity and generalizability of these methods.
Furthermore, the construction of complete predictive models requires the integration of increasingly varied
information and the evaluation of other clinical aspects. The revolutionary effect of machine learning (ML) in
predicting cancer recurrence is highlighted in this cutting-edge literature review. Even though a number of
algorithms show promise for bettering patient outcomes in cancer, further research and development—especially
in the areas of deep learning and ensemble methods—is necessary. Predictive models must use a variety of datasets
and clinical parameters in order to achieve complete accuracy. The advantages that might result from continued
research are numerous and include improved survival rates and tailored treatment regimens. This study acts as a
beacon, emphasizing the necessity of continued research endeavors, clinical trial validation, and ML development
in order to fully achieve the technology's potential to transform cancer care.
Keywords: Machine Learning, Cancer, Recurrence prediction, Support Vector Machine, Deep Learning, CNN,
ANN.

1. INTRODUCTION
Cancer is a complicated and deadly illness that still presents many difficulties for researchers
studying medicine. Cancer recurrence continues to be a serious worry for patients and
healthcare providers despite advancements in treatment choices. To create customized
treatment programs and enhance patient outcomes, it's critical to identify individuals who are
at a high risk of experiencing a cancer recurrence [1, 2, 3]. Machine learning techniques have
emerged as very effective tools in a number of industries, including healthcare, in recent years.
Through the analysis of enormous data sets and the identification of patterns that standard
statistical approaches could overlook, these techniques have demonstrated promise in the
prediction of cancer recurrence. The goal of this extensive evaluation of the literature is to
ascertain the present level of knowledge regarding machine learning methods for cancer

775 | V 1 9 . I 0 1
 DOI: 10.5281/zenodo.10559810

recurrence prediction [4, 5]. Large volumes of data, including genetic information, imaging
data, clinical factors, and even text-based reports, may be processed using machine learning
algorithms. These algorithms can identify trends and forecast future results by being trained on
patient data from the past with known outcomes. Machine learning algorithms are able to
produce precise predictions based on the unique characteristics of each patient when
forecasting the recurrence of cancer by concurrently analyzing several factors [6, 2, 7]. This
review of the literature looks at many devices that are used to forecast the recurrence of
malignancies, including ovarian, colon, breast, lung, and prostate cancers. We give a summary
of the many kinds of machine learning algorithms that are applied in this domain, together with
an analysis of their benefits and drawbacks [8, 6]. Furthermore, this research looks at the
salient characteristics or factors that have shown to be most effective in predicting cancer
recurrence using machine learning models. These variables can be any combination of
radiological data taken from medical pictures (tumor shape or texture), biomarkers (gene
expression profiles), clinical information (tumor stage, histological grade), and demographic
characteristics (age, gender) [9, 2]. This study also covers performance criteria, such as
concordance index (C-index), area under the curve (AUC), specificity, and sensitivity, which
are used to assess the prediction accuracy of various machine learning models. These
measurements' advantages and disadvantages in assessing the potency of various machine
learning techniques are emphasized [10, 11]. Through a careful analysis of the available
research, this review seeks to provide light on the state of machine learning methods for
predicting cancer recurrence.
To further increase the precision and therapeutic application of these models, research gaps and
obstacles are noted [11]. This thorough literature analysis will demonstrate how machine
learning techniques may be used to predict the recurrence of cancer. Researchers can create
more resilient designs that can enhance clinical decision-making, enhance patient outcomes,
and finally pave a new path in cancer research by comprehending the advantages and
disadvantages of various methodologies [11]. Millions of individuals worldwide are impacted
by the complicated disease known as cancer. In clinical practice, cancer recurrence continues
to be a severe concern despite great advancements in therapy. The capacity to precisely
anticipate the return of cancer has the potential to greatly influence patient outcomes by
facilitating customized treatment regimens and prompt interventions. Recent research has
shown that machine learning algorithms are effective in predicting the return of cancer and
have shown encouraging findings [12, 13, and 14].
Recurrence of cancer after initial diagnosis and therapy is referred to as cancer recurrence.
Numerous biochemical, genetic, and environmental variables all play a role in this
multifactorial process. Clinical characteristics such tumor size, stage, and histological
characteristics are the foundation of conventional techniques for forecasting cancer recurrence.
Nevertheless, these methods frequently lack accuracy and fail to adequately convey the
disease's complexity [15, 16]. An alternate method is offered by machine learning techniques,
which employ computational algorithms to evaluate vast volumes of data and spot patterns that
are invisible to the human eye. With the integration of many data sources, including genetic
profiles, imaging data, clinical records, and patient data, these approaches have demonstrated

776 | V 1 9 . I 0 1
 DOI: 10.5281/zenodo.10559810

tremendous potential in the prediction of cancer recurrence [17, 18]. Supervised learning is a
popular machine learning method for forecasting cancer recurrence. Using this method, he
trains models on labeled data where each sample's outcome—a cancer recurrence—is known.
The model discovers patterns and correlations between input properties (such gene expression
levels) and output variables (iterations) by examining this labeled dataset.
The feature values of the trained model may be used to forecast the likelihood of a new sample
reoccurring [19, 20, 21, 17]. Unsupervised learning is another popular method. It seeks to
identify clusters and hidden patterns in unlabeled datasets. Large genomic or proteomic
datasets may be processed using unsupervised learning techniques, which do not require
previous knowledge of particular genes or proteins linked to recurrence risk. These algorithms
may uncover novel biomarkers or risk factors for cancer recurrence by grouping individuals
with comparable molecular profiles or clinical traits [22, 18]. In addition, the ability of deep
learning approaches to automatically extract characteristics from high-dimensional data has
drawn interest in recent years. These algorithms can predict cancer recurrence based on minor
patterns that may not be identified using conventional methods when applied to medical
imaging data or clinical text reports [22, 23, and 15]. By providing more precise and
individualized risk assessment, machine learning approaches for cancer recurrence prediction
have the potential to completely transform clinical practice. Through the integration of many
data sources and the utilization of computer algorithms, these techniques offer fresh insights
into the intricate process of cancer recurrence. Large-scale clinical studies will be necessary to
evaluate and improve these machine learning models as this field of study develops, in order
to guarantee their dependability and practicality in real-world clinical settings [14, 17, and 21].

2. LITERATURE REVIEW
Cancer is a complex and life-threatening illness that impacts millions of individuals globally.
Recurrence of cancer is still a serious concern in oncology despite tremendous progress in
medicine. A recurrence of cancer occurs when the disease returns following a time of remission
or after effective therapy. Because it significantly affects treatment plans, patient survival, and
general quality of life, this is a crucial problem [24, 25, 26]. Clinical characteristics including
tumor size, stage, histological grade, and lymph node metastases have historically been used
to predict the likelihood of cancer recurrence. However, the accuracy and individual prediction
of these conventional approaches are limited. As a result, 4,444 researchers looked at different
strategies for applying machine learning techniques to predict the recurrence of cancer [27, 28,
29].
In order to create algorithms that can learn from data without explicit programming, computer
science and statistics are combined in the multidisciplinary topic of machine learning. It
exhibits tremendous promise in a number of areas, such as cancer and healthcare. Machine
learning algorithms analyze 4,444 massive datasets of clinical factors, genetic information,
imaging results, and other pertinent data to find trends and create prediction models for cancer
recurrence [30, 31, 32]. With early discovery and individualized treatment plans, there is
potential to enhance patient outcomes, which is why machine learning approaches to predict

777 | V 1 9 . I 0 1
 DOI: 10.5281/zenodo.10559810

cancer recurrence are important. In order to treat recurring cancer, early identification is crucial
since it enables prompt management before the illness worsens. Physicians can successfully
prevent or manage relapse by using more proactive monitoring measures and individualized
treatment regimens by properly identifying patients at high risk of relapse through the use of
machine learning models [33, 27, 34]. Furthermore, machine learning approaches may
incorporate several data sources that older methods sometimes do not fully take into account.
For instance, genetic information offers important information on tumor features that may
affect risk and prognosis.
But grasping it with only standard methods is difficult. Researchers can create more precise
models to predict cancer recurrence by combining genetic data with clinical characteristics
using machine learning methods like random forests and artificial neural networks [35, 36].
Creating customized treatment plans based on anticipated recurrence risk is another way to
improve patient care. Physicians can identify patients who might benefit from immunotherapy,
targeted treatment, or adjuvant therapy with the use of machine learning algorithms. Treatment
strategies can be customized to each patient's risk profile in order to minimize adverse effects
and healthcare costs, optimize treatment efficacy, and eliminate needless treatments [37, 26,
30].
In oncology, using machine learning methods to forecast cancer recurrence has a lot of promise
to enhance patient outcomes. Through the utilization of data analysis and pattern recognition
algorithms, machine learning models are capable of producing precise predictions grounded on
extensive clinical and genetic data. These predictions may be used to develop tailored treatment
regimens and early diagnosis, which can significantly improve cancer patients' quality of life,
optimize treatment outcomes, and increase survival rates. [35, 38, 39]. The purpose of the
ensuing evaluation of the literature is to examine the state of machine learning-based cancer
recurrence prediction at the moment and pinpoint areas that require more investigation [36].
Since cancer recurrence significantly affects patient outcomes and survival rates, it is a crucial
concern in the treatment of cancer. Recurrence of cancer may be accurately predicted, which
can aid in the creation of customized treatment programs and enhance patient outcomes.
Through examination of diverse clinical and genetic data, advances in technology and machine
learning algorithms have demonstrated promising results in predicting the recurrence of cancer.
Through an analysis of his 4,444 relevant publications, this review of the literature seeks to
determine how machine learning algorithms might be used to predict the recurrence of cancer
[40, 41]. A popular machine learning approach for classification problems like predicting the
recurrence of cancer is support vector machines (SVM). It operates by determining the best
hyperplane to divide several classes according to the input characteristics.
SVM algorithms have been effectively employed in a number of studies to predict the
recurrence of cancer by taking into account variables including tumor size, lymph node
involvement, and gene expression patterns [42, 43]. RF is an ensemble learning technique that
creates predictions by combining many decision trees. Because of its ability to handle high-
dimensional data and comprehend intricate correlations between factors, it is frequently
employed to forecast the recurrence of cancer. The RF-based approach has demonstrated

778 | V 1 9 . I 0 1
 DOI: 10.5281/zenodo.10559810

encouraging outcomes in identifying critical characteristics linked to cancer recurrence, such

as: B Protein expression level or genetic variation [44, 45, 46]. Neural networks seen in the
human brain serve as the inspiration for the ANN computational model. They are made up of
networked nodes, often known as "neurons," which interpret data and forecast outcomes by
applying patterns discovered from incoming information. ANNs have been applied to the
prediction of cancer recurrence using a variety of clinical indicators, histological findings, and
genetic profile data with impressive effectiveness [47, 46]. Using a series of consecutive
integrations of many weak predictive models, GBM is an ensemble approach that iteratively
constructs a strong predictive model. Large datasets may be processed with ease using the
GBM method, which is also an effective tool for identifying intricate feature interactions that
are necessary for precise cancer recurrence prediction [48].
A branch of machine learning called "deep learning" makes use of multilayer artificial neural
networks. Its capacity to autonomously learn hierarchical representations from raw data has
garnered significant interest in recent years. Convolutional neural networks (CNNs), one type
of deep learning model, have demonstrated promise in the analysis of medical pictures and the
extraction of information pertinent to the prediction of cancer recurrence [49, 48, 47].
Traditional statistical approaches may be enhanced by machine learning algorithms, which
have shown to be useful in the prediction of cancer recurrence. A number of machine learning
techniques, including deep learning models like support vector machines, random forests,
artificial neural networks, gradient-boosting machines, and CNNs, have been shown to be
successful in the reviewed literature.
These algorithms shed light on the intricate relationships between genetic and clinical variables
linked to cancer recurrence [48, 41]. To enhance patient care and outcomes, more research is
necessary to validate and apply these algorithms in clinical settings [48]. In the field of
oncology, cancer recurrence is a significant problem as it has an immediate impact on patient
survival and quality of life. The promise of machine learning techniques to predict cancer
recurrence has drawn interest for years. This review of the literature aims to provide a thorough
analysis of the current machine learning methods for cancer recurrence prediction, highlighting
their advantages, disadvantages, and potential applications [50, 51, 52]. With the use of
electronic databases like IEEE Artificial Intelligence and PubMed, as well as it’s many blends.
Numerous machine learning methods were found to be employed in the prediction of cancer
recurrence by this investigation. They include the commonly used artificial neural networks
(ANNs), deep learning techniques, random forests (RFs), and support vector machines
(SVMs). SVM performed better than other models because it could handle high-dimensional
data efficiently. Interpretability was preserved while resilience against noise and outliers was
offered by RF. Deep learning techniques performed better on big datasets than ANNs, despite
ANNs demonstrating promising outcomes in capturing complicated correlations in data [50,
51, 52, 53]. A few research papers have extracted. Numerous aspects were employed.
These features, which offer useful information about tumor properties, include shape
descriptors, tissue analysis metrics, or radiomics features [50, 52]. Furthermore, prediction
accuracy was greatly increased by including clinical data such as age, tumor stage, histological

779 | V 1 9 . I 0 1
 DOI: 10.5281/zenodo.10559810

grade, and molecular markers. The most informative features for precise prediction models
were found using feature selection methods including recursive feature removal and
evolutionary algorithms [52, 53].
While machine learning techniques have been remarkably successful in predicting cancer
recurrence, there are still inherent limits. Robust model development and validation are
hampered by the absence of big, well-annotated datasets. Furthermore, it is challenging to
compare the findings of various research because to the lack of uniformity in feature extraction
methods and model assessment criteria [47, 51]. The development of standardized procedures
for feature extraction, dataset gathering, and model assessment should be the main goal of
future approaches to overcome these difficulties. Prediction accuracy may also be increased by
combining genomic or proteomic data and integrating multimodal data sources [50, 52]. This
review of the literature offers a thorough examination of the machine learning techniques
currently in use for cancer recurrence prediction. Despite encouraging outcomes, more
investigation is required to resolve current issues and create a solid model that can be applied
in clinical settings. Accurately predicting cancer recurrence has the potential to greatly enhance
patient outcomes and drive individualized treatment regimens due to the ongoing development
of machine learning techniques and the growing availability of 4,444 high-quality datasets [51,
53].

3. CONCLUSION
To sum up, this current review of the literature emphasizes how machine learning techniques
may help in cancer recurrence prediction. The examined papers show how different algorithms
and methods may effectively discover patterns and provide highly accurate predictions about
the recurrence of cancer. Still, there's opportunity for research and development in this field.
To increase the prediction capacity and generalization of these algorithms, his future research
should concentrate on utilizing cutting-edge developments in machine learning, such as deep
learning models and ensemble approaches [48, 50, 53].
In addition, for complete prediction models, efforts should be made to incorporate more varied
datasets and take additional clinical aspects into account [53]. This cutting-edge overview of
the literature concentrates on how machine learning is revolutionizing the field of cancer
recurrence prediction. The efficiency exhibited by several algorithms indicates a hopeful
avenue for enhancing patient outcomes within the cancer field. While deep learning and
ensemble approaches have made significant strides, more investigation and improvement are
required. Predictive models should use a variety of datasets and clinical parameters in order to
achieve complete accuracy. The advantages might be enormous, ranging from raising survival
rates to maximizing customized treatment regimens. In order to fully fulfill machine learning's
promise to change cancer management, further research, clinical trial validation, and
development are needed, as this review acts as a beacon of light.

780 | V 1 9 . I 0 1
 DOI: 10.5281/zenodo.10559810

References
1) M. Shi and B. Zhang , "Semi-supervised learning improves gene expression-based prediction of cancer
recurrence" September 4, 2011. Doi:10.1093/bioinformatics/btr502.
2) A. Vial et al., "A review of the role of radiomic feature extraction and deep learning in cancer-specific
predictive modeling," Research on translational cancer, June 1, 2018. Doi:10.21037/tcr.2018.05.02.
3) G. Kelly, "AI may enhance colorectal cancer recurrence prediction: Mayo Clinic study," News Network,
Mayo Clinic, September 12, 2022.
4) J. Mazaki and colleagues, "Auto-artificial Intelligence-Based Novel Prediction Model for Colon Cancer
Recurrence," Anticancer Research, Sep. 01, 2021. Doi:10.21873/anticanres.15276
5) M. Ertel, A. Mengad and S. Amali, “A Comparative Study of Machine Learning Techniques to Predict Types
of Breast Cancer Recurrence”, International Journal of Advanced Computer Science and Applications, vol.
14, no. 5, 2023, Doi: 10.14569/ijacsa.2023.0140531.
6) M. R. Fu et al., "Machine learning for breast cancer survivors' lymphedema detection," mHealth, May 01,
2018. Doi:10.21037/mHealth.2018.04.02.
7) S. R. Gupta, "Prediction time of breast cancer tumor recurrence using machine learning." Cancer Treatment
and Research Communications, Jan. 01, 2022, Doi:10.1016/j.ctarc.2022.100602.
8) A. Mosayebi, B. Mojaradi, A. Bonyadi Naeini, and S. H. Khodad Hosseini "Modeling and comparing data
mining algorithms for prediction of recurrence of breast cancer", PLOS ONE, vol. 15, no. 10, p. e0237658,
Oct. 2020, Doi: 10.1371/journal.pone.0237658.
9) D. Parapadakis, "Is it possible for artificial intelligence to anticipate a learner's needs? Learnings from
forecasting student contentment, London Review of Education, 18(2), 2020, Doi: 10.14324/lre.18.2.03.
10) C.-H. Tsai and Y.-H. Hu, "Application of Machine Learning Techniques to Development of Emergency
Medical Rapid Triage Prediction Models in Acute Care." In CIN: Computers, Informatics, Nursing, Dec.
2023, Doi: 10.1097/cin.0000000000001057.
11) J.-J. Nunez, B. Leung, C. Ho, A. T. Bates, and R. T. Ng, "Using Natural Language Processing to Predict the
Survival of Cancer Patients From Their Initial Oncology Consultation Document," JAMA Network Open,
vol. 6, no. 2, p. e230813, Feb. 20,23, Doi: 10.1001/jamanetworkopen.2023.0813.
12) Tsai, C.-H. and Hu, Y.-H , "Application of Machine Learning Techniques to Development of Emergency
Medical Rapid Triage Prediction Models in Acute Care" CIN: Computers, Informatics, Nursing, December
2023 Doi: 10.1097/cin.0000000000001057.
13) J.-J. Nunez, B. Leung, C. Ho, A. Bates, and R. T. Ng, "Predicting the Survival of Patients with Cancer From
Their Initial Oncology Consultation Document Using Natural Language Processing," JAMA network to
launch on February 27, 2023. Doi:10.1001/jamanetworkopen.2023.0813.
14) M. Savage, "Utilizing tumor DNA to identify cancer recurrence sooner | GSK." The cancer recurrence tumor
and CTDNA technology, https://www.gsk.com/en-gb/behind-the-science-magazine/
15) K. Kokolus, Labroots, "Developing Methods to Predict Breast Cancer Recurrence Finding ways to forecast
the recurrence of breast cancer” May 19, 2022, https://www.labroots.com/trending/cancer/22783
16) B. Azman, S. Hussain, N. F. I. B. M. Azmi, M. Ghani, and N. Norlen , "Prediction of Distant Recurrence in
Breast Cancer using a Deep Neural Network," Revista Internacional De Metodos Numericos Para Calculo
Y Diseno En Ingenieria, Jan. 01, 2022. ttps://doi.org/10.23967/j.rimni.2022.03.006.

781 | V 1 9 . I 0 1
 DOI: 10.5281/zenodo.10559810

17) Lorena González-Castro , Marcela Chávez , Patrick Duflot , Valérie Bleret , Alistair G Martin , Marc
Zobel , Jama Nateqi , Simon Lin , José J Pazos-Arias , Guilherme Del Fiol and Martín López-Nores ,
"Machine Learning Algorithms to Predict Breast Cancer Recurrence Using Structured and Unstructured
Sources from Electronic Health Records" On May 13, 2023, Cancers. Doi:10.3390/cancers15102741.
18) D. Shao et al., "Artificial intelligence in clinical research of cancers," Briefings in Bioinformatics, December
21, 2021, Doi: 10.1093/bib/bbab523
19) G. M. Hemphill, "A Review of Popular Machine Learning Techniques for Modeling and Predicting Cancer
Recurrence," Sep. 27, 2016. Doi: 10.2172/1329544.
20) J.-J. Nunez, B. Leung, C. Ho, A. Bates, and R. T. Ng , "Predicting the Survival of Patients with Cancer From
Their Initial Oncology Consultation Document Using Natural Language Processing," JAMA network,
February 27, 2023. Doi:10.1001/jamanetworkopen.2023.0813.
21) C. L. Soh et al., "Present and future of machine learning in breast surgery: systematic review.", British
Journal of Surgery, August 10, 2022, Doi:10.1093/bjs/znac224.
22) M. Rahimi, A. Akbari, F. Asadi, and H. Emami, “A comprehensive study of machine learning methods for
cervical cancer survival prediction” BMC Cancer, 13 April 2023. Doi:10.11865-023-08808-3.
23) M. Sugimoto, S. Hikichi, M. Takada, and M. Toi, "Machine learning techniques for breast cancer diagnosis
and treatment: a narrative review", Annals of Breast Surgery on March 1, 2023. Doi:10.21037/abs-21-63
24) M. Savage, "Utilizing tumor DNA to identify cancer recurrence sooner | GSK.", The cancer recurrence tumor
and CTDNA technology, https://www.gsk.com/en-gb/behind-the-science-magazine/
25) C. C. M. Professional, Cleveland Clinic, "Cancer Recurrence." Cancer recurrence (article number 24872-2),
https://my.clevelandclinic.org/health
26) K. Kokolus, Labroots, May 19, 2022, "Developing Methods to Predict Breast Cancer Recurrence." Finding
ways to forecast the recurrence of breast cancer: https://www.labroots.com/trending/cancer/22783
27) B. Zhang, H. Shi, and H. Wang , "Machine Learning and AI in Cancer Prognosis, Prediction, and Treatment
Selection: A Critical Approach" Journal of Multidisciplinary Healthcare in June 2023, Doi:
10.2147/jmdh.s410301.
28) A. Gregory, "AI tool accurately predicts tumour regrowth in cancer patients." The Guardian, Cancer AI tool
predicts tumor regrowth, April 23, 2022:
29) J. MAZAKI and colleagues, "A New Auto-artificial Intelligence-Based Prediction Model for Colon Cancer
Recurrence," Anticancer Research, vol. 41, no. 9, pp. 4629–4636, Sep. 20, 21, Doi:
10.21873/anticanres.15276.
30) G. M. Hemphill, "A Review of New Machine Learning Techniques for Modeling and Predicting Cancer
Recurrence," Sep. 27, 2016. This link points to 10.2172/1329544.
31) A. Lorenc, A. Ro maszko–Wojtowicz, Ł. Jaśkiewicz, A. Doboszyńska, and A. Buciński,, "Exploring the
efficacy of artificial neural networks in predicting lung cancer recurrence: a retrospective study based on
patient records." , Translational lung cancer research, Oct. 01, 2023, The URL is 10.21037/tlcr-23-350.
32) Daphne Lyn G. Rivera, RN Roison Andro Narvaez, MSN RN, “Application of Machine Learning Approaches
in Cancer Prediction.", Canadian Journal of Nursing Informatics, https://cjni.net
33) A. Dasgupta et al., "Using quantitative ultrasound and radiomics to predict recurrence in patients with locally
advanced breast cancer," Oncotarget, Dec. 07, 2021. Doi:10.18632/oncotarget.2813.

782 | V 1 9 . I 0 1
 DOI: 10.5281/zenodo.10559810

34) M. Chakkouch, M. Ertel, A. Mengad, and S. Amali, A Comparative Study of Machine Learning Techniques
to Predict Types of Breast Cancer Recurrence”, International Journal of Advanced Computer Science and
Applications, Jan. 01, 2023. Doi:10.14569/ijacsa.2023.0140531.
35) H. Kim, S. J. Lee, S. J. Park, I. Y. Choi, and S. Hong, "Machine Learning Approach to Predict the Probability
of Recurrence of Renal Cell Carcinoma After Surgery: Prediction Model Development Study", Medical
informatics journal, March 1, 2021. Doi:10.2196/25635.
36) M. Rahimi, A. Akbari, F. Asadi, and H. Emami, "Cervical cancer survival prediction by machine learning
algorithms: a systematic review", BMC Cancer, Apr. 13, 2023. Doi:10.11865-023-08808-3.
37) R. R. Gujjuri et al., "Estimating When Patients With Esophageal Cancer Will Recur After Esophagectomy
and How Long It Will Take," Annals of Surgery, July 15, 2022, Doi:10.1097/sla.0000000000005538.
38) G. S. Raj, "Time Based Prediction of Breast Cancer Tumor Recurrence Using Machine Learning."
International Journal of Clinical Biostatistics and Biometrics, June 30, 2022, Doi:10.23937/2469-
5831/1510046.
39) M. N. Haqu et al., "Predicting Characteristics Associated with Breast Cancer Survival Using Multiple
Machine Learning Approaches", Computational and Mathematical Methods in Medicine, Apr. 25, 2022,
DOI:10.1155/2022/1249692
40) A. Mosayebi, B. Mojaradi, A. B. Naeini, and S. H. K. Hosseini, “Modeling and comparing data mining
algorithms for prediction of recurrence of breast cancer”, PLOS ONE, Oct. 15, 2020.
Doi:10.1371/journal.pone.0237658.
41) H. Izci et al., "Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population
Level with Administrative Data." Clinical Epidemiology, May 01, 2023; Doi:10.2147/clep.s400071.
42) M. Melchionna et al, "Deep-Learning Algorithm Can Detect Cancer Spread Following Surgery", Health
ITAnalytics, October 27, 2022.
43) D. Shao et al "Artificial intelligence in clinical research of cancers," Dec. 21, 2021, Briefings in
Bioinformatics, DOI:10.1093/bib/bbab52.
44) L. González-Castro et al., "Machine Learning Algorithms to Predict Breast Cancer Recurrence Using
Structured and Unstructured Sources from Electronic Health Records," May 15, 2023, vol. 15, no. 10, p.
2741, Doi: 10.3390/cancers15102741.
45) A. Lorenc, A. Romaszko–Wojtowicz, Ł. Jaśkiewicz, A. Doboszyńska, and A. Buciński, “a retrospective
study based on patient data to investigate the effectiveness of artificial neural networks in predicting lung
cancer recurrence” In Translational Lung Cancer Research, Oct. 01, 2023. https://doi.org/10.21037/tlcr-23-
350
46) Tucci L., Burns E. "What is machine learning and how does it operate? comprehensive manual Business AI,
September 15, 2023. Technology Target, Inc./Search Enterprise AI/Definition/Machine Learning (ML)
47) A. Vial et al., "A review of the role of radiomic feature extraction and deep learning in cancer-specific
predictive modeling," Research on translational cancer, June 1, 2018. Doi:10.21037/tcr.2018.05.02.
48) D. Shao et al., "Artificial intelligence in clinical research of cancers.", Briefings in Bioinformatics, Dec. 21,
2021; 10.1093/bib/bbab523.
49) Y. Jeon, "Recurrence after curative resection for rectal cancer: a machine learning based prediction,"
December 15, 2023, PLOS ONE. 10.1371/journal.pone.0290141.
50) B. Azman, S. Hussain, N. F. I. B. M. Azmi, M. Ghani, and N. Norlen, ”Prediction of Distant Recurrence in
Breast Cancer Using a Deep Neural Network”, Revista Internacional De Metodos Numericos Para Calculo
Y Diseno En Ingenieria, Jan. 01, 2022. ttps://doi.org/10.23967/j.rimni.2022.03.006

783 | V 1 9 . I 0 1
 DOI: 10.5281/zenodo.10559810

51) Z. Zou, D. Chang, H. Liu, and Y. Xiao, "Current updates in machine learning in the prediction of therapeutic
outcome of hepatocellular carcinoma: what should we know?", Insights into Imaging, Mar. 06, 2021.
10.1186/s13244-021-00977-9.
52) M. Kirola, "Optimized Data Mining, Machine Learning, and Deep Learning Techniques for Breast Cancer
Prediction in Big Data Context: A Comprehensive Review Study", Journal of Biomedical and Pharmacology,
March 31, 2022, https://biomedpharmajournal.org/vol15no1/.
53) J. Li et al., "A narrative review of artificial intelligence-assisted decision making for lung cancer patients'
prognosis and drug efficacy prediction," Thoracic Disease Journal, December 1, 2021. Doi:10.21037/jtd-21-
864.

784 | V 1 9 . I 0 1